[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-345612-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-345612-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","knocking-down-cldn7-enhanced-the-effect-of-cisplatin-in-oc-cells-by-regulating-mitophagy-research-open-access","Knocking down CLDN7 enhanced the effect of cisplatin in OC cells by regulating mitophagy - Research Open Access","","Ovarian cancer (OC) remains a leading cause of female mortality, driven by complex progression and limited early screening, while cisplatin resistance undermines standard chemotherapy. Claudins, particularly CLDN7, are implicated in cancer biology, yet its role in OC and cisplatin chemoresistance is unclear. This study integrates bioinformatics and multiple experimental assays to evaluate CLDN7 function and its relationship with autophagy/mitophagy and treatment response.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/knocking-down-cldn7-enhanced-the-effect-of-cisplatin-in-oc-cells-by-regulating-mitophagy-research-open-access/345612/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/knocking-down-cldn7-enhanced-the-effect-of-cisplatin-in-oc-cells-by-regulating-mitophagy-research-open-access/345612.png","ImageObject",300,407,{"name":42,"@type":43},"Riley","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What problem does the study address in ovarian cancer treatment?","Question",{"text":63,"@type":64},"The study targets cisplatin resistance in ovarian cancer and aims to clarify the mechanisms behind chemotherapy failure and poor outcomes.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which role does CLDN7 appear to play according to the findings?",{"text":68,"@type":64},"CLDN7 is elevated in ovarian cancer and increased in cisplatin-resistant SKOV3/DDP cells, where it is linked to higher autophagy and mitophagy.",{"name":70,"@type":61,"acceptedAnswer":71},"How does knocking down CLDN7 affect cisplatin sensitivity and tumor behavior?",{"text":72,"@type":64},"Silencing CLDN7 reduces autophagy/mitophagy-related proteins, decreases migration and invasion in SKOV3/DDP cells, and enhances cisplatin’s inhibitory effect on tumor growth in xenograft models.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},345612,1790943779,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1374391975076,"https://ap-avatar.wpscdn.com/avatar/14000253ca4ec9f6853?x-image-process=image/resize,m_fixed,w_180,h_180&k=1783305029341752051","Zheng et al. Journal of Ovarian Research (2026) 19:213 Journal of Ovarian Research  \n[https://doi.org/10.1186/s13048-026-02121-x](https://doi.org/10.1186/s13048-026-02121-x)  \nRESEARCH Open Access  \nKnocking down CLDN7 enhanced the effect of cisplatin in OC cells by regulating mitophagy  \nXiushuang Zheng1†, Bingbing Hu2†, Qing Xu3†, Liqun Wang1, Bing Han4* and Kexin Wang1*  \nAbstract  \nBackground Ovarian cancer (OC) remains a leading cause of female mortality due to its complex pathological progression and the lack of early screening methods. The cisplatin chemotherapy resistance is a stumbling block in the treatment of ovarian cancer. Aberrant expression of Claudins (CLDNs) has been implicated in several cancers including OC, especially CLDN7, while the vital roles of CLDN7 in OC and cisplatin chemoresistance remain unclear. Methods ONCOMINE, GEPIA, the Human Protein Atlas, cBioPortal databases, CCK-8 assay, RT-PCR, Western Blot, transwell assay, Immunofluorescence (IF), rescue experiment and in vivo xenograft experiments, were utilized in this study.  \nResults Our research found that CLDN7 is preferentially enriched on the cytoplasmic membrane of SKOV3 cells. The expression level of CLDN7 was elevated in ovarian cancer, indicating its association with the occurrence of ovarian cancer. We discovered that CLDN7 was significantly increased in SKOV3/DDP cells, with enhanced autophagy and mitophagy levels. To further explore the possible mechanism of CLDN7 in cisplatin resistance, we knocked down CLDN7 in SKOV3/DDP cells and found that autophagy and mitophagy related proteins decreased, suggesting that CLDN7 maybe involved in cisplatin resistance by regulating autophagy and mitophagy. Colocalization of LC3 with mitochondria (MitoTracker) by immunofluorescence provides direct evidence of mitophagy. The migration and invasion ability of SKOV3/DDP cells decreased when CLDN7 was knocked down. The xenograft models experiment results indicated that silencing CLDN7 could enhance the inhibitory effect of cisplatin on tumor growth.  \nConclusion Knocking down CLDN7 enhanced the effect of cisplatin in OC cells by regulating mitophagy.This provides a theoretical basis for cisplatin resistance in future studies in OC.  \nKeywords Ovarian Cancer (OC), Claudin7 (CLDN7), Chemoresistance, Mitophagy, Autophagy  \n†Xiushuang Zheng, Bingbing Hu and Qing Xu contributed equally to this work.  \n*Correspondence:  \nBing Han [hanbing@hrbmu.edu.cn](hanbing@hrbmu.edu.cn)[ ](hanbing@hrbmu.edu.cn)Kexin Wang [wangkexin1234@163.com](wangkexin1234@163.com)  \n1Department of Gynecology and Obstetrics, The First Affiliated Hospital of Harbin Medical University, 23 Youzheng Street, Nangang District, Harbin 150001, China  \n2Center for Reproduction and Genetics, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, Suzhou, China 3Central Operating Room, The Sixth Affiliated Hospital of Harbin Medical University, Harbin, China  \n4Department of Radiation Oncology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permis","cbCaijv99FaxDDnk","https://ap.wps.com/l/cbCaijv99FaxDDnk","pdf",4257223,14,"English","# Background\n# Methods\n# Results\n# Conclusion","[{\"question\":\"What problem does the study address in ovarian cancer treatment?\",\"answer\":\"The study targets cisplatin resistance in ovarian cancer and aims to clarify the mechanisms behind chemotherapy failure and poor outcomes.\"},{\"question\":\"Which role does CLDN7 appear to play according to the findings?\",\"answer\":\"CLDN7 is elevated in ovarian cancer and increased in cisplatin-resistant SKOV3/DDP cells, where it is linked to higher autophagy and mitophagy.\"},{\"question\":\"How does knocking down CLDN7 affect cisplatin sensitivity and tumor behavior?\",\"answer\":\"Silencing CLDN7 reduces autophagy/mitophagy-related proteins, decreases migration and invasion in SKOV3/DDP cells, and enhances cisplatin’s inhibitory effect on tumor growth in xenograft models.\"}]","Knocking down CLDN7 enhanced the effect of cisplatin in OC cells by regulating mitophagy - Research Open Access | PDF",1790058301,35,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e81bbb4bb55def096ca25f96c6ef87b8.webp",983,1310,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7718e6d7b728299475cf37499bdf9990.webp",982,1309,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/29bf62c925bc20d8686215a4e4c4dc3e.webp",981,1308,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a7b4a9c92390120e3745a8d1bc41c5d3.webp",980,1306]